Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022166
Filing Date
2016-08-03
Accepted
2016-08-02 20:38:47
Documents
51
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 Q2 2016 10_Q 06302016 vsar-10q_20160630.htm 10-Q 1335837
2 EX-10.1 CTR VSAR OM MFG AGRMT vsar-ex101_541.htm EX-10.1 397312
3 EX-31.1 vsar-ex311_10.htm EX-31.1 16713
4 EX-31.2 vsar-ex312_6.htm EX-31.2 16425
5 EX-32.1 vsar-ex321_7.htm EX-32.1 5119
  Complete submission text file 0001564590-16-022166.txt   4481079

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vsar-20160630.xml EX-101.INS 839890
7 XBRL TAXONOMY EXTENSION SCHEMA vsar-20160630.xsd EX-101.SCH 27783
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsar-20160630_cal.xml EX-101.CAL 24867
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsar-20160630_def.xml EX-101.DEF 63789
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsar-20160630_lab.xml EX-101.LAB 199955
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsar-20160630_pre.xml EX-101.PRE 150665
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 244106690 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 161802034
SIC: 2834 Pharmaceutical Preparations